Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
- Status
- COMPLETED
- Phase
- N/A
A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC
- Status
- UNKNOWN
- Phase
- NA
Breath Combined With CT for Diagnoses of Pulmonary Nodules
- Status
- UNKNOWN
- Phase
- N/A
Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MR-Linac Guided Adaptive FSRT for Brain Metastases From Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)
- Status
- TERMINATED
- Phase
- N/A
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
- Status
- TERMINATED
- Phase
- PHASE1